Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
暂无分享,去创建一个
[1] T. Sargeant,et al. Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease , 2023, Autophagy.
[2] M. Bhat,et al. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model , 2022, The Journal of Neuroscience.
[3] R. Nixon,et al. Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques , 2022, Nature Neuroscience.
[4] Simiao Chen,et al. Role of Calcium Homeostasis in Alzheimer’s Disease , 2022, Neuropsychiatric disease and treatment.
[5] V. Cavalli,et al. FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury , 2022, The Journal of biological chemistry.
[6] L. Puskás,et al. Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain , 2021, The Journal of Neuroscience.
[7] G. Cantarella,et al. Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease? , 2020, Frontiers in Neuroscience.
[8] Asad Ali,et al. Does Obesity Increase the Risk of Dementia: A Literature Review , 2018, Cureus.
[9] T. Iida,et al. Role of autophagy in the pathogenesis of inflammatory bowel disease , 2017, World journal of gastroenterology.
[10] Nirmal Singh,et al. Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia , 2017, Pharmacology Biochemistry and Behavior.
[11] M. Fakhoury. Immune-mediated processes in neurodegeneration: where do we stand? , 2016, Journal of Neurology.
[12] G. Taglialatela,et al. Reduced Incidence of Dementia in Solid Organ Transplant Patients Treated with Calcineurin Inhibitors , 2015, Journal of Alzheimer's disease : JAD.
[13] Justus J. Randolph,et al. A Step-by-Step Guide to Propensity Score Matching in R , 2014 .
[14] K. Kuwata,et al. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice , 2013, Autophagy.
[15] A. Hakim,et al. Heart disease as a risk factor for dementia , 2013, Clinical epidemiology.
[16] C. Bauvy,et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion , 2013, Cell Research.
[17] H. Eguchi,et al. Rapamycin Causes Upregulation of Autophagy and Impairs Islets Function Both In Vitro and In Vivo , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] G. Taglialatela,et al. A Role for Calcineurin in Alzheimer’s Disease , 2011, Current neuropharmacology.
[19] Smita Majumder,et al. Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits , 2011, Alzheimer's & Dementia.
[20] Gary King,et al. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .
[21] Amy L. Byers,et al. Depression and risk of developing dementia , 2011, Nature Reviews Neurology.
[22] C. Norris,et al. Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture , 2011, Aging cell.
[23] G. Taglialatela,et al. Amyloid‐β oligomers impair fear conditioned memory in a calcineurin‐dependent fashion in mice , 2010, Journal of neuroscience research.
[24] Fred H. Gage,et al. Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.
[25] G. Taglialatela,et al. Neuroimmunomodulation by calcineurin in aging and Alzheimer's disease. , 2010, Aging and disease.
[26] H. Abdul,et al. Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling , 2009, The Journal of Neuroscience.
[27] Jen‐Hau Chen,et al. Risk factors for dementia. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.
[28] G. Taglialatela,et al. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition , 2009, Behavioural Brain Research.
[29] G. Taglialatela,et al. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta , 2008, Aging cell.
[30] S. Berg,et al. Overweight and Obesity in Old Age Are Not Associated with Greater Dementia Risk , 2008, Journal of the American Geriatrics Society.
[31] G. Taglialatela,et al. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice , 2007, Neurobiology of Learning and Memory.
[32] K. Tomizawa,et al. Truncation and Activation of Calcineurin A by Calpain I in Alzheimer Disease Brain* , 2005, Journal of Biological Chemistry.
[33] S. Nishimura,et al. Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] I. Mansuy. Calcineurin in memory and bidirectional plasticity. , 2003, Biochemical and biophysical research communications.
[35] Hongkui Zeng,et al. Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.
[36] W. Almawi,et al. Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] K. Tanaka,et al. Effect of Cyclosporin Analogues and FK506 on Transcellular Transport of Daunorubicin and Vinblastine via P-glycoprotein , 1996, Pharmaceutical Research.
[38] J. Heitman,et al. Immunosuppressant Target Protein FKBP12 Is Required for P-Glycoprotein Function in Yeast* , 1996, The Journal of Biological Chemistry.
[39] J. Heitman,et al. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin , 1995, Current opinion in nephrology and hypertension.
[40] T. Terasaki,et al. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. , 1993, Biochemical pharmacology.
[41] K. Kawahara,et al. INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE , 1993, Transplantation.
[42] D. Begley,et al. Permeability of the Blood‐Brain Barrier to the Immunosuppressive Cyclic Peptide Cyclosporin A , 1990, Journal of neurochemistry.
[43] S. Son,et al. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice. , 2010, Journal of Alzheimer's disease : JAD.
[44] D. Rubinsztein,et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies , 2009, Cell Death and Differentiation.
[45] R. Abraham,et al. Immunopharmacology of rapamycin. , 1996, Annual review of immunology.